SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease
Open Access
- 11 November 2017
- journal article
- research article
- Published by Wiley in Aging Cell
- Vol. 17 (1), e12679
- https://doi.org/10.1111/acel.12679
Abstract
Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Despite decades of study, effective treatments for AD are lacking. Mitochondrial dysfunction has been closely linked to the pathogenesis of AD, but the relationship between mitochondrial pathology and neuronal damage is poorly understood. Sirtuins (SIRT, silent mating type information regulation 2 homolog in yeast) are NAD-dependent histone deacetylases involved in aging and longevity. The objective of this study was to investigate the relationship between SIRT3 and mitochondrial function and neuronal activity in AD. SIRT3 mRNA and protein levels were significantly decreased in AD cerebral cortex, and Ac-p53 K320 was significantly increased in AD mitochondria. SIRT3 prevented p53-induced mitochondrial dysfunction and neuronal damage in a deacetylase activity-dependent manner. Notably, mitochondrially targeted p53 (mito-p53) directly reduced mitochondria DNA-encoded ND2 and ND4 gene expression resulting in increased reactive oxygen species (ROS) and reduced mitochondrial oxygen consumption. ND2 and ND4 gene expressions were significantly decreased in patients with AD. p53-ChIP analysis verified the presence of p53-binding elements in the human mitochondrial genome and increased p53 occupancy of mitochondrial DNA in AD. SIRT3 overexpression restored the expression of ND2 and ND4 and improved mitochondrial oxygen consumption by repressing mito-p53 activity. Our results indicate that SIRT3 dysfunction leads to p53-mediated mitochondrial and neuronal damage in AD. Therapeutic modulation of SIRT3 activity may ameliorate mitochondrial pathology and neurodegeneration in AD.Keywords
Funding Information
- National Institutes of Health (R01AG054156-01)
- National Research Foundation (2014R1A2A1A11052685, 2016M3C7A1904233)
- National Research Council of Science and Technology (CRC-15-04-KIST)
- Ministry of Science, ICT and Future Planning
- Korea Institute of Science and Technology (2E26663)
This publication has 58 references indexed in Scilit:
- Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's DiseaseAntioxidants and Redox Signaling, 2012
- Lack of p53 Decreases Basal Oxidative Stress Levels in the Brain Through Upregulation of Thioredoxin-1, Biliverdin Reductase-A, Manganese Superoxide Dismutase, and Nuclear Factor Kappa-BAntioxidants and Redox Signaling, 2012
- p53 Opens the Mitochondrial Permeability Transition Pore to Trigger NecrosisCell, 2012
- Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric RestrictionCell, 2010
- Electron tunneling in respiratory complex IProceedings of the National Academy of Sciences of the United States of America, 2010
- p53-Induced Growth Arrest Is Regulated by the Mitochondrial SirT3 DeacetylasePLOS ONE, 2010
- SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylationNature, 2010
- Biophysical characterizations of human mitochondrial transcription factor A and its binding to tumor suppressor p53Nucleic Acids Research, 2009
- SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosisThe EMBO Journal, 2007
- p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cellsNeuroscience Letters, 2007